Back
Inhibrx 10K Form
Buy
52
INBX
Inhibrx
Last Price:
20.48
Seasonality Move:
-23.06%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive INBX News And Ratings
See the #1 stock for the next 7 days that we like better than INBX
INBX Financial Statistics
Sales & Book Value
| Annual Sales: | $2.18M |
|---|---|
| Cash Flow: | $-55.06M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.74 |
| Price / Book: | 7.66 |
Profitability
| EPS (TTM): | -4.25000 |
|---|---|
| Net Income (TTM): | $-188.67M |
| Gross Margin: | -- |
| Return on Equity: | -660.05% |
| Return on Assets: | -72.83% |
Inhibrx Earnings Forecast
Key Inhibrx Financial Ratios
- The Research & Development expenses have been 5,054.59% of Revenue.
- The Interest Expense is -11.09% of Operating Income.
- The Net Earning history of INBX is -6,661.93% of Total Revenues.
- Per Share Earnings over the last 6 years have been positive in 1 years.
Inhibrx Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Current Symbol: | INBX |
| Website: | inhibrx.com |
Debt
| Debt-to-Equity Ratio: | 1.59 |
|---|---|
| Current Ratio: | 10.16 |
| Quick Ratio: | 9.44 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |